Rebetol

DRUG3 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer, Merck Sharp & Dohme LLC

Conditions

Chronic Hepatitis CHepatitis C

Phase 2

A Study Evaluating the Safety and Clinical Activity of HCV-796 in Treatment-Naive and Non-Responder Subjects

CompletedNCT00367887

Wyeth is now a wholly owned subsidiary of PfizerHepatitis C

Start: 2006-10-31End: 2008-07-31Updated: 2013-02-11

Unknown Phase

Impact of Patient Support by the Medical Staff on Adherence to Therapy With PegIntron Plus Rebetol (Study P04413)

CompletedNCT00704964

Merck Sharp & Dohme LLCChronic Hepatitis C, Hepatitis C

Start: 2005-05-31End: 2009-10-31Updated: 2015-10-06

Study of Patients With Chronic Hepatitis C Infected With HCV LVL G1 and Effect of Peg-Intron Plus Rebetol Treatment (Study P04793)

CompletedNCT00709228

Merck Sharp & Dohme LLCHepatitis C

Start: 2006-05-31End: 2008-11-30Updated: 2015-01-26